Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

5.0K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.0K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.3K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EECFS: Efficient Ensemble Causal Feature Selection for High-Dimensional Molecular Data.

Journal of chemical information and modeling·2026
Same author

MVCL: A Contrastive Learning Model with Multi-view Networks for Driver Gene Prediction.

IEEE journal of biomedical and health informatics·2026
Same author

Occurrence, size-fractionated distribution, and human exposure risks of organic ultraviolet absorbers in urban road dust across China.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Pathogenicity prediction for noncanonical splice-altering variants based on multimodal feature fusion.

Briefings in bioinformatics·2026
Same author

AdPrST:An Adversarial Graph Deep Learning Pre-clustering Framework for Deciphering Spatiotemporal Structures in Spatially Resolved Transcriptomics.

IEEE transactions on computational biology and bioinformatics·2026
Same author

Ultrafast cascaded energy transfer triggers highly luminescent Te<sup>4+</sup>-doped Cs<sub>2</sub>ZrCl<sub>6</sub> perovskites.

Optics letters·2026
Same journal

miRNAProtPred: computational prediction of human miRNA binding based on seed complementarity and thermodynamic stability.

Frontiers in genetics·2026
Same journal

Enhancing cereal productivity via nitrogen use efficiency: from conventional breeding to modern genomics.

Frontiers in genetics·2026
Same journal

Transcriptomic analysis reveals FcγR-mediated phagocytosis as a key pathway for the anti-inflammatory action of <i>Polygonatum sibiricum</i> polysaccharides in loach.

Frontiers in genetics·2026
Same journal

A novel <i>ABO</i> splice site variant underlying the A<sub>3</sub> phenotype: immunogenetic basis and functional dissection.

Frontiers in genetics·2026
Same journal

Case Report: Identification of two novel <i>ALMS1</i> variants in a patient with a ciliopathy resembling Alström syndrome.

Frontiers in genetics·2026
Same journal

Integrative analysis identifies Hspa5 as a key regulator of the ERS/UPR-immune axis in spinal cord injury.

Frontiers in genetics·2026
See all related articles

Related Experiment Video

Updated: Aug 2, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K

PredDSMC: A predictor for driver synonymous mutations in human cancers.

Lihua Wang1, Jianhui Sun1, Shunshuai Ma1

  • 1Key Laboratory of Intelligent Computing and Signal Processing of Ministry of Education and Information Materials and Intelligent Sensing Laboratory of Anhui Province, Institutes of Physical Science and Information Technology, Anhui University, Hefei, Anhui, China.

Frontiers in Genetics
|April 13, 2023
PubMed
Summary
This summary is machine-generated.

Synonymous mutations, often overlooked, can drive cancer development. A new computational tool, PredDSMC, accurately identifies these driver synonymous mutations, improving cancer research. This method enhances understanding of cancer genetics.

Keywords:
cancerdriver mutationmachine learningmutation predictionsynonymous mutation

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.8K

Related Experiment Videos

Last Updated: Aug 2, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.8K

Area of Science:

  • Genomics
  • Cancer Biology
  • Computational Biology

Background:

  • Driver mutations are key to cancer development, with most research focusing on missense mutations.
  • Emerging evidence highlights the significant role of synonymous mutations as drivers in human cancers.
  • Accurate identification of driver synonymous mutations is crucial for understanding cancer progression.

Purpose of the Study:

  • To develop and validate PredDSMC, a computational method for predicting driver synonymous mutations in human cancers.
  • To systematically explore multimodal features for improved prediction accuracy.
  • To differentiate driver synonymous mutations from passenger mutations.

Main Methods:

  • Exploration of four feature categories: sequence, splicing, conservation, and functional scores.
  • Systematic feature selection to enhance model performance and reduce redundancy.
  • Development of the PredDSMC model using a random forest classifier.

Main Results:

  • PredDSMC demonstrated superior performance in distinguishing driver from passenger synonymous mutations.
  • Validation on two independent test sets confirmed the method's accuracy.
  • The model effectively utilizes multimodal features for precise prediction.

Conclusions:

  • PredDSMC is a valuable computational tool for predicting driver synonymous mutations.
  • This method offers a deeper understanding of the role of synonymous mutations in human cancers.
  • PredDSMC advances the field of cancer genomics and personalized medicine.